Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jeffrey D. Krimmel-Morrison"'
Autor:
Jeanne Fredrickson, Yuezheng Zhang, Jeffrey D. Krimmel-Morrison, Talayeh Ghezelayagh, Kathryn T. Baker, Rosa Ana Risques, Elizabeth M. Swisher, Mary J. Emond, Barbara M. Norquist, Enna Hun, Marc R. Radke, Shenyi Lian, Daniela Nachmanson
Publikováno v:
Gynecol Oncol
Objective Pap tests hold promise as a molecular diagnostic for serous ovarian cancer, but previous studies reported limited sensitivity. Furthermore, the presence of somatic mutations in normal tissue is increasingly recognized as a challenge to the
Publikováno v:
J Gen Intern Med
Lifelong learning in medicine is an important skill and ethical obligation, but many residents do not feel prepared to be effective self-directed learners when training ends. The learning sciences offer evidence to guide self-directed learning, but t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4cb124bd470f091fee9d1161df8547
https://europepmc.org/articles/PMC9086009/
https://europepmc.org/articles/PMC9086009/
Autor:
Jeffrey D. Krimmel-Morrison, B. Norquist, Jeanne Fredrickson, Brendan F. Kohrn, Enna Manhardt, Rosa Ana Risques, Talayeh Ghezelayagh, Elizabeth M. Swisher, Marc R. Radke
Publikováno v:
Clinical Research (Excluding Clinical Trials).
Objective: The use of Pap tests as a molecular diagnostic for high-grade serous ovarian carcinoma (HGSC) is a promising concept, but studies to detect tumor DNA report limited sensitivity. “Cancer-like” somatic mutations from clonal expansions in
Autor:
Rosana Risques, Talayeh Ghezelayagh, Enna Manhardt, Jeanne Fredrickson, Marc R. Radke, Brendan F. Kohrn, Elizabeth M. Swisher, Barbara M. Norquist, Jeffrey D. Krimmel-Morrison
Publikováno v:
Gynecologic Oncology. 162:S153-S154
Objectives: The use of Pap tests as a molecular diagnostic for high-grade serous ovarian carcinoma (HGSC) is a promising concept, but studies to detect tumor DNA report limited sensitivity. ‘Cancer-like’ somatic mutations from clonal expansions i
Autor:
Jeffrey D. Krimmel-Morrison, Marc R. Radke, Enna Hun, Shenyi Lian, Kathryn T. Baker, Mary J. Emond, Daniela Nachmanson, Jeanne Fredrickson, Elizabeth M. Swisher, Yuezheng Zhang, Rosa Ana Risques, Barbara M. Norquist
Publikováno v:
Clinical Cancer Research. 26:B40-B40
Objective: The development of Pap tests as a molecular diagnostic for serous ovarian cancer is a promising concept, but previous studies reported limited sensitivity. In addition, the presence of cancer-associated somatic mutations in normal tissue i